A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor
Taking innovative research from concept to application is critical for improving health care systems and the well-being of patients. VCHRI is proud to support investigators and their groundbreaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
The 2022 Innovation and Translational Research Award recipients are:
What arguably began with the Fitbit has evolved into a technological space where runners can choose from a variety of wearables to monitor training progress with every stride.
It is here — at the intersection of ease of use and reliability — that Dr. Chris Napier, a sports physiotherapist and principal investigator at the Vancouver Coastal Health Research Institute (VCHRI), is studying wearable technology.
Researchers from the University of British Columbia (UBC) and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.
The researchers say the study is an important step toward developing a potential functional cure for type 1 diabetes.
May is Vision Health Month. With screens ever-present — and the time we spend staring at them ever-increasing — eye fatigue is a common occurrence. The inability to focus, intermittent mild blurry vision, tension headaches and dry or itchy eyes are all signs that you may need to see your optometrist for a checkup. Vancouver Coastal Health Research Institute researcher Dr. David Albiani answers a few common questions related to eye strain and screen time.
In the first study of its kind, a global team of researchers are investigating the safety and effectiveness of the CorNeat KPro synthetic cornea in people with corneal blindness. The fully artificial cornea could be a game-changer for patients with corneal blindness, replacing the need for human donations and providing a much-needed alternative for patients who did not respond to current technology.
